Moneycontrol BureauShare of Nutraplus India rose 17.5 percent as it will start commercial production from first week of September 2015 at Plant N-92, MIDC Tarapur Maharashtra."The said plant is multipurpose API plant and set up with the total installed capacity of 360 MT per annum of various kinds of high end multi specialty API products in therapeutic & analgesic segment of pharma industry," as per BSE release.The products stated above are used by various pharma formulation units worldwide to manufacture the therapeutic & analgesic category of pharma products.At 11:06 hrs Nutraplus India was quoting at Rs 271.40, up Rs 17.80, or 7.02 percent. It has touched a 52-week high of Rs 298 on the BSE.Posted by Rakesh Patil
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
